Nanocrystal News and Research

RSS
Industrial Biotechnology presents insights on cellulose nanocrystal toxicity

Industrial Biotechnology presents insights on cellulose nanocrystal toxicity

Janssen announces submission of NDA for three-month paliperidone palmitate

Janssen announces submission of NDA for three-month paliperidone palmitate

Luminescent nanocrystals tags with high-speed scanning technology detects multiple viruses within minutes

Luminescent nanocrystals tags with high-speed scanning technology detects multiple viruses within minutes

A window to the brain: an interview with Professor Guillermo Aguilar, UC Riverside's Bourns College of Engineering (BCOE)

A window to the brain: an interview with Professor Guillermo Aguilar, UC Riverside's Bourns College of Engineering (BCOE)

Study suggests silicon nanocrystals may be safe tool for diagnostic imaging in humans

Study suggests silicon nanocrystals may be safe tool for diagnostic imaging in humans

Metallurgists use microwave oven to produce nanocrystal semiconductors

Metallurgists use microwave oven to produce nanocrystal semiconductors

Scientists develop super-sensitive test that could detect diseases earlier

Scientists develop super-sensitive test that could detect diseases earlier

ACS symposium focuses on biomimetics

ACS symposium focuses on biomimetics

New process can create LEDs that produce light in the UV range

New process can create LEDs that produce light in the UV range

Elan fourth quarter total revenue increases 18% to $271.0 million

Elan fourth quarter total revenue increases 18% to $271.0 million

Elan's third quarter total revenue increases 17% to $328.5 million

Elan's third quarter total revenue increases 17% to $328.5 million

Decline of citrate concentration may contribute to bone brittleness

Decline of citrate concentration may contribute to bone brittleness

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Elan Drug Technologies, Alkermes merge to form new company in Ireland

EDT receives European approval for XEPLION injection to treat schizophrenia

EDT receives European approval for XEPLION injection to treat schizophrenia

Elan 2010 total revenue increases 5% to $1,169.7 million

Elan 2010 total revenue increases 5% to $1,169.7 million

Life Technologies announces early stage results from SMS technology

Life Technologies announces early stage results from SMS technology

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Elan Drug Technologies issues statement on FDA approval of AMPYRA

Elan Drug Technologies issues statement on FDA approval of AMPYRA

Approval of injectable formulation using NanoCrystal technology announced

Approval of injectable formulation using NanoCrystal technology announced

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.